We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.72B
AUM Growth
+$29.7M
Cap. Flow
+$160M
Cap. Flow %
5.89%
Top 10 Hldgs %
47.84%
Holding
110
New
9
Increased
24
Reduced
22
Closed
12

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$71.7M
2
BHVN icon
Biohaven
BHVN
+$47.3M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$42.1M
4
SYY icon
Sysco
SYY
+$38.9M
5
AAPL icon
Apple
AAPL
+$34.8M

Top Sells

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$48M
2
CI icon
Cigna
CI
+$45.6M
3
MCK icon
McKesson
MCK
+$30.5M
4
VZ icon
Verizon
VZ
+$23M
5
BCYC
Bicycle Therapeutics
BCYC
+$22.8M

Sector Composition

Rank Sector Weight
1 Healthcare 58.96%
2 Technology 10.09%
3 Communication Services 6.22%
4 Consumer Discretionary 5.49%
5 Financials 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GS icon
26
Goldman Sachs
GS
$316B
$35.3M 1.3%
77,948
-31,942
-29% -$14M
ORCL icon
27
Oracle
ORCL
$416B
$34.6M 1.27%
245,114
+48,440
+25% +$6.02M
GE icon
28
GE Aerospace
GE
$397B
$32.6M 1.2%
204,957
-54,974
-21% -$8.78M
ERAS icon
29
Erasca
ERAS
$6.37B
$32.5M 1.19%
+13,768,039
New +$29.7M
CRH icon
30
CRH
CRH
$66.7B
$32.4M 1.19%
431,984
+96,404
+29% +$7.69M
AVBP icon
31
ArriVent BioPharma
AVBP
$1.44B
$31.8M 1.17%
1,712,703
+148,994
+10% +$2.66M
MCD icon
32
McDonald's
MCD
$195B
$28.1M 1.03%
+110,434
New +$29.3M
FERG icon
33
Ferguson
FERG
$49.2B
$28.1M 1.03%
145,040
-24,240
-14% -$5.08M
TSLA icon
34
Tesla
TSLA
$1.28T
$26.7M 0.98%
+134,913
New +$23.6M
VZ icon
35
Verizon
VZ
$189B
$25.2M 0.92%
609,904
-569,548
-48% -$23M
CMG icon
36
Chipotle Mexican Grill
CMG
$43.9B
$25M 0.92%
398,500
– –
PEPG icon
37
PepGen
PEPG
$133M
$24.3M 0.89%
1,520,932
– –
PROK icon
38
ProKidney
PROK
$334M
$23M 0.84%
9,341,266
+5,473,419
+142% +$14.7M
STRO icon
39
Sutro Biopharma
STRO
$425M
$22.6M 0.83%
770,869
+193,050
+33% +$7.63M
BSX icon
40
Boston Scientific
BSX
$69.1B
$19.4M 0.71%
251,689
-51,346
-17% -$3.76M
PINS icon
41
Pinterest
PINS
$13.4B
$18.1M 0.66%
409,951
+14,100
+4% +$556K
ZURA icon
42
Zura Bio
ZURA
$532M
$17M 0.63%
4,860,939
+2,010,939
+71% +$8.2M
FULC icon
43
Fulcrum Therapeutics
FULC
$288M
$15.8M 0.58%
2,541,046
-307,440
-11% -$2.33M
ABEO icon
44
Abeona Therapeutics
ABEO
$382M
$15.6M 0.57%
+3,685,503
New +$18.8M
RCUS icon
45
Arcus Biosciences
RCUS
$3.59B
$14.6M 0.54%
957,304
– –
JNJ icon
46
Johnson & Johnson
JNJ
$619B
$13.2M 0.48%
90,097
– –
BNTC icon
47
Benitec Biopharma
BNTC
$424M
$11.8M 0.43%
1,691,290
+1,487,070
+728% +$11M
IMTX icon
48
Immatics
IMTX
$1.26B
$11M 0.4%
946,563
– –
SNY icon
49
Sanofi
SNY
$103B
$10.2M 0.38%
210,701
– –
IFRX icon
50
InflaRx
IFRX
$261M
$9.98M 0.37%
5,733,910
– –
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return

Suvretta Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Suvretta Capital Management held 110 positions worth $2.72B, up 1.1% from $2.69B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Suvretta Capital Management deployed $160M of net new capital in Q2 2024, opening 9 new positions and adding to 24 existing holdings. Its largest new stake was Sysco: 520,900 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 58% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Cigna, an estimated $45.6M trimmed.

  • Suvretta Capital Management's largest Q2 2024 buy was Sysco: 520,900 shares worth $37.2M.
  • Suvretta Capital Management added most to UnitedHealth in Q2 2024, an estimated $71.7M increase.
  • Suvretta Capital Management's biggest Q2 2024 reduction was Cigna, cutting an estimated $45.6M.
  • Suvretta Capital Management fully exited argenx in Q2 2024, selling an estimated $48M.
  • Suvretta Capital Management's ten largest holdings make up 48% of its $2.72B portfolio in Q2 2024.
  • Suvretta Capital Management opened 9 new positions and closed 12 in Q2 2024.
  • Suvretta Capital Management's portfolio value rose 1.1% quarter-over-quarter to $2.72B.

Based on Suvretta Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.